Factors associated with unreliable liver stiffness measurement and its failure with transient elastography in the Chinese population

Journal of Gastroenterology and Hepatology (Australia)

Volumn 26, Issue 2, 2011, Pages 300-305

  Wong, Grace L H ^a   Wong, Vincent W S ^a   Chim, Angel M L ^a   Yiu, Karen K L ^a   Chu, Shirley H T ^a   Li, Mia K P ^a   Chan, Henry L Y ^a  

^a CHINESE UNIVERSITY OF HONG KONG   (Hong Kong)

Author keywords

Central obesity; Fibroscan; Obesity; Underweight

Indexed keywords

ADULT; ARTICLE; BODY MASS; CHINESE; DIAGNOSTIC TEST; ELASTOGRAPHY; FEMALE; HUMAN; LIVER STIFFNESS MEASUREMENT; MAJOR CLINICAL STUDY; MALE; OBESITY; PRIORITY JOURNAL; RISK FACTOR; WAIST CIRCUMFERENCE;

EID: 78851470616     PISSN: 08159319     EISSN: 14401746     Source Type: Journal    
DOI: 10.1111/j.1440-1746.2010.06510.x     Document Type: Article

References (28)

1. Lok ASF, McMahon BJ. Chronic hepatitis B. Hepatology 2007; 45: 507-39.
2. Liaw YF, Leung N, Kao JH etal. Asian-Pacific consensus statement on the management of chronic hepatitis B: a 2008 update. Hepatol. Int. 2008; 2: 263-83.
3. European Association For The Study Of The Liver. EASL clinical practice guidelines: management of chronic hepatitis B. J. Hepatol. 2009; 50: 227-42.
4. Bravo AA, Sheth SG, Chopra S. Liver biopsy. N. Engl. J. Med. 2001; 344: 495-500.
5. Castéra L, Negre I, Samii K, Buffet C. Pain experienced during percutaneous liver biopsy. Hepatology 1999; 30: 1529-30.
6. Bedossa P, Dargère D, Paradise V. Sampling variability of liver fibrosis in chronic hepatitis C. Hepatology 2003; 38: 1449-57.
7. The French METAVIR Cooperative Study Group. Intraobserver and interobserver variations in liver biopsy interpretation in patients with chronic hepatitis C. Hepatology 1994; 20: 15-20.
8. Chan HLY. Revisit on the treatment recommendation of chronic hepatitis B. Hepatology 2009; 49: 700.
9. Fraquelli M, Rigamonti C, Casazza G etal. Reproducibility of transient elastography in the evaluation of liver fibrosis in patients with chronic liver disease. Gut 2007; 56: 968-73.
10. Talwalkar JA, Kurtz DM, Schoenleber SJ etal. Ultrasound-based treatment transient elastography for the detection of hepatic fibrosis: systemic review and meta-analysis. Clin. Gastroenterol. Hepatol. 2007; 5: 1214-20.
11. Friedrich-Rust M, Ong MF, Martens S etal. Performance of transient elastography for the staging of liver fibrosis: a meta-analysis. Gastroenterology 2008; 134: 960-74.
12. Wong GLH, Wong VWS, Choi PCL etal. Increased liver stiffness measurement by transient elastography in severe acute exacerbation of chronic hepatitis B. J. Gastroenterol. Hepatol. 2009; 24: 1002-7.
13. Wong GLH, Wong VWS, Choi PCL etal. Metabolic syndrome increases the risk of liver cirrhosis in chronic hepatitis B. Gut 2009; 58: 111-7.
14. Malik R, Afdhal N. Stiffness and impedance: the new liver biomarkers. Clin. Gastroenterol. Hepatol. 2007; 5: 1144-6.
15. Castéra L, Foucher J, Bernard PH etal. Pitfalls of liver stiffness measurement: a 5-year prospective study of 13369 examinations. Hepatology 2010; 51: 828-35.
16. Lucidarme D, Foucher J, Le Bail B etal. Factors of accuracy of transient elastography (fibroscan) for the diagnosis of liver fibrosis in chronic hepatitis C. Hepatology 2009; 49: 1083-9.
17. Chan HLY, de Silva HJ, Leung NWY etal. How should we manage patients with non-alcoholic fatty liver disease in 2007? J. Gastroenterol. Hepatol. 2007; 22: 801-8.
18. Krawitt EL. Autoimmune hepatitis. N. Engl. J. Med. 2006; 354: 54-66.
19. Kaplan MM, Gershwin ME. Primary biliary cirrhosis. N. Engl. J. Med. 2005; 353: 1261-73.
20. World Health Organization Obesity: Preventing and Managing the Global Epidemic: Report of a WHO Consultation. Geneva, Switzerland: World Health Organization; 2000. WHO Technical Report Series, 894.
21. Grundy SM, Cleeman JI, Daniels SR etal. American Heart Association, National Heart, Lung and Blood Institute: diagnosis and management of the metabolic syndrome: an American Heart Association/National Heart, Lung, and Blood Institute Scientific Statement. Circulation 2005; 112: 2735-52.
22. Foucher J, Chanteloup E, Vergniol J etal. Diagnosis of cirrhosis by transient elastography (Fibroscan): a prospective study. Gut 2006; 55: 403-8.
23. Sandrin L, Fourquet B, Hasquenoph JM etal. Transient elastography: a new noninvasive method for assessment of hepatic fibrosis. Ultrasound Med. Biol. 2003; 29: 1705-13.
24. Kettaneh A, Marcellin P, Douvin C etal. Features associated with success rate and performance of FibroScan measurements for the diagnosis of cirrhosis in HCV patients: a prospective study of 935 patients. J. Hepatol. 2007; 46: 628-34.
25. Wong VWS, Vergniol J, Wong GLH etal. Diagnosis of fibrosis and cirrhosis using liver stiffness measurement in nonalcoholic fatty liver disease. Hepatology 2010; 51: 454-62.
26. Nobili V, Vizzutti F, Arena U etal. Accuracy and reproducibility of transient elastography for the diagnosis of fibrosis in pediatric nonalcoholic steatohepatitis. Hepatology 2008; 48: 442-8.
27. de Lédinghen V, Vergniol J, Foucher J etal. Feasibility of liver transient elastography with FibroScan using a new probe for obese patients. Liver Int. 2010; 30: 1043-8.
28. Friedrich-Rust M, Hadji-Hosseini H, Kriener S etal. Transient elastography with a new probe for obese patients for non-invasive staging of non-alcoholic steatohepatitis. Eur. Radiol. 2010; 20: 2390-6. Jun 6. [Epub ahead of print].